After an ibuprofen and aspirin overdose, which is more appropriate to use for gastric protection: famotidine (H2‑blocker) or omeprazole (proton‑pump inhibitor)?

Omeprazole is Superior for Gastric Protection After Ibuprofen and Aspirin Overdose

After an ibuprofen and aspirin overdose, omeprazole (a proton pump inhibitor) is the preferred agent for gastric protection over famotidine (an H2-blocker). PPIs provide more potent and sustained acid suppression, which is critical for preventing and healing NSAID-related gastric injury that occurs after overdose.

Rationale Based on Evidence

Superior Acid Suppression with PPIs

The fundamental issue after NSAID/aspirin overdose is severe gastric mucosal injury from both direct toxicity and prostaglandin inhibition. PPIs inhibit the final step of acid production at the parietal cell proton pump, achieving approximately 80-97% reduction in 24-hour intragastric acidity 1. This profound acid suppression is essential because:

• Traditional doses of H2-receptor antagonists provide inadequate acid suppression and do not prevent most NSAID-related gastric ulcers 1
• Even double-dose H2-blockers show inferior efficacy compared to standard-dose PPIs 1, 2
• Omeprazole's antisecretory effect lasts up to 72 hours despite a short plasma half-life, due to prolonged binding to the proton pump 3

Clinical Evidence Favoring PPIs

Multiple studies demonstrate PPI superiority:

• PPIs have been proven superior to ranitidine (an H2RA) in preventing NSAID ulcer recurrence and controlling symptoms 1
• In aspirin users with prior ulcer bleeding, omeprazole significantly reduced recurrent gastroduodenal mucosal breaks (19.8% vs 33.8% with famotidine, p=0.045) 4
• A 2014 retrospective study showed omeprazole reduced recurrent ulcers/erosions to 9.1% versus 30.6% with famotidine (p=0.005) in aspirin users 5
• Animal studies confirm omeprazole prevents acute gastric mucosal erosions more effectively than famotidine 6

Practical Considerations in Overdose Setting

In the acute overdose context:

• Omeprazole 20-40 mg daily is the appropriate dose 1, 3
• Onset of antisecretory effect occurs within 1 hour, with maximum effect at 2 hours 3
• The drug should ideally be given with food within 30 minutes of dosing for optimal effect 1
• Treatment should continue for at least several weeks given the severity of mucosal injury expected from overdose

Important Caveats

Common pitfall: Do not assume H2-blockers provide adequate protection simply because they reduce acid. The level of acid suppression with standard H2RA doses is insufficient for NSAID-related gastric injury 1.

Monitoring consideration: While omeprazole overdose itself is generally benign (doses up to 2400 mg reported with only transient symptoms) 3, the primary concern is managing the NSAID/aspirin toxicity and preventing GI bleeding complications.

Drug interaction note: Since the patient has taken aspirin, be aware that ibuprofen can interfere with aspirin's antiplatelet effects, though this is less relevant in the acute overdose/toxicity management phase 7.

Clinical Algorithm

1. Initiate omeprazole 40 mg once daily immediately (higher dose justified given severity of exposure)
2. Monitor for signs of GI bleeding (hematemesis, melena, hemoglobin drop)
3. Continue PPI therapy for minimum 4-8 weeks to allow complete mucosal healing
4. Consider endoscopy if symptoms develop or bleeding occurs
5. Do not substitute with famotidine, as it provides inadequate gastroprotection in this high-risk scenario

The evidence consistently demonstrates that PPI therapy is the rational choice over H2RAs for NSAID-related gastric protection 1, and this principle applies with even greater force in the overdose setting where mucosal injury is expected to be severe.